HepCBC’s April Bulletin
Posted On: Wednesday, April 15th, 2015
Category: Hepatitis
CATIE News – A community-based program successfully engages participants in hepatitis C care
Posted On: Thursday, April 2nd, 2015
Despite the availability of a cure, many people living with hepatitis C are not being tested, diagnosed, linked to care and treated for hepatitis C. A study of the American hepatitis C continuum of care found that only 50% of people living with hepatitis C are aware of their status, 43% have accessed care, 27%… Read more »
BC adds two curative hepatitis C drugs to provincial drug plan
Posted On: Friday, March 27th, 2015
Two new, often curative, hepatitis C drugs are now provided under British Columbia’s public drug plan coverage, Minister of Health Terry Lake announced on Monday, March 23, 2015. People with hepatitis C will be able to apply tomorrow for coverage under B.C.’s PharmaCare program of Sovaldi (sofosbuvir) and Harvoni (ledipasvir and sofosbuvir). These new medications… Read more »
HepCBC’s March Bulletin
Posted On: Friday, March 20th, 2015
CATIE’s HepC Info Update 6.5
Posted On: Wednesday, March 18th, 2015
New and Noteworthy Holkira Pak cures 94% of people co-infected with Hep C and HIV High cure rates for Harvoni in people co-infected with HIV and Hep C Hep C testing program in an emergency department finds undiagnosed older adults with Hep C
CATIE News – Canadian HCV guidelines updated for 2015
Posted On: Friday, March 13th, 2015
Hepatitis C virus (HCV) infects the liver and, if left untreated, eventually causes serious injury to this vital organ, leading to complications, liver failure and, in some cases, liver cancer. In the past year, combinations of new and powerful oral medications to treat HCV have been licensed in Canada. To help doctors, nurses and other… Read more »
Pacific Hepatitis C Network Wants Your Treatment Stories
Posted On: Wednesday, March 11th, 2015
The number of treatment stories has been growing during the past 5 years as thousands of people have participated in clinical trials for hepatitis C Direct Acting Antivirals (DAAs). As data from these clinical trials continues to emerge, so do the personal treatment stories and experiences of people who have been treated with these new… Read more »
AVI – Healthcare and Service Provider ‘Lunch and Learn’: Hepatitis C
Posted On: Wednesday, March 11th, 2015
AVI presents a ‘Lunch & Learn’ on the topic of Hepatitis C for Healthcare and Service Providers. They will cover the basics of hepatitis C including testing, transmission, and community resources, followed by an update on current and upcoming treatments provided by treatment nurses. Light lunch and refreshments provided. Victoria: Wednesday March 25th 12:00pm-2:00pm Access… Read more »
CATIE’s HepCinfo Update 6.4
Posted On: Wednesday, March 4th, 2015
New and Noteworthy P.E.I. announces their hepatitis C strategy Community-based program successful at linking people to Hep C testing and care
CATIE’s HepCInfo Updates 6.3
Posted On: Tuesday, February 24th, 2015
New and Noteworthy Vertical transmission of hepatitis C estimated to occur in over 5% of births in women with hepatitis C According to a systematic review on vertical transmission of hepatitis C, the estimated risk for transmission of hepatitis C to the fetus during pregnancy is 5.8%, reported researchers in Clinical Infectious Diseases. With hepatitis… Read more »
CATIE’s HepCInfo Updates 6.2
Posted On: Wednesday, February 11th, 2015
New and Noteworthy Screening Canadians born between 1945 and 1965 could be cost effective According to a modelling study, one-time screening for people 25 to 64 or 45 to 64 years of age could be cost-effective, reported researchers in the Canadian Medical Association Journal. For both age ranges the researchers modelled four options: No screening… Read more »
HepCBC’s February Bulletin
Posted On: Wednesday, February 11th, 2015